Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

YISRAEL KADOSH

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1417917907
CMS profile
109259
Location
LAKEWOOD, NJ

General Payments · PY2019–2025

$2,565.43

  • Reported across 133 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$252.16

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $252.16 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $142.25 7
Novo Nordisk AS $46.22 3
PFIZER INC. $33.02 2
NOVARTIS PHARMACEUTICALS CORPORATION $15.51 1
E.R. Squibb & Sons, L.L.C. $15.16 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $247.56 17
PY2020 $52.06 4
PY2021 $428.17 24
PY2022 $512.09 24
PY2023 $605.30 27
PY2024 $468.09 23
PY2025 $252.16 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $18.43 02/04/2025 Food and Beverage Undisputed 06/30/2026 1240777442 CMS
Abbott Laboratories $18.84 04/07/2025 Food and Beverage Undisputed 06/30/2026 1240781378 CMS
Abbott Laboratories $20.26 04/25/2025 Food and Beverage Undisputed 06/30/2026 1240782185 CMS
Abbott Laboratories $20.90 06/17/2025 Food and Beverage Undisputed 06/30/2026 1240784627 CMS
Abbott Laboratories $20.90 07/08/2025 Food and Beverage Undisputed 06/30/2026 1240768542 CMS
Abbott Laboratories $21.38 09/09/2025 Food and Beverage Undisputed 06/30/2026 1240635315 CMS
Abbott Laboratories $21.54 11/21/2025 Food and Beverage Undisputed 06/30/2026 1240774246 CMS
E.R. Squibb & Sons, L.L.C. $15.16 06/12/2025 Food and Beverage Undisputed 06/30/2026 1184538444 CMS
Novartis Pharmaceuticals Corporation $15.51 05/08/2025 Food and Beverage Undisputed 06/30/2026 1200281426 CMS
Novo Nordisk Inc $15.88 02/27/2025 Food and Beverage Undisputed 06/30/2026 1188764192 CMS
Novo Nordisk Inc $15.29 03/27/2025 Food and Beverage Undisputed 06/30/2026 1189161228 CMS
Novo Nordisk Inc $15.05 08/21/2025 Food and Beverage Undisputed 06/30/2026 1188978369 CMS
PFIZER INC. $15.09 01/16/2025 Food and Beverage Undisputed 06/30/2026 1229004436 CMS
PFIZER INC. $17.93 05/01/2025 Food and Beverage Undisputed 06/30/2026 1229181597 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.